Vistin Pharma ASA (OSL:VISTN) Receipts from Customers

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSL:VISTN Vistin Pharma ASA OSL:VISTN
78 GF Score
Price kr18.50
GF Value kr23.70
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Vistin Pharma ASA Receipts from Customers?

Receipts from Customers only applicable to companies reporting Cash Flow from Operations in direct method.

OSL:VISTN
78GF Score
Vistin Pharma ASA OSL:VISTN
Receipts from Customers is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vistin Pharma ASA (OSL:VISTN) Overvalued in 2026?

Based on GuruFocus' analysis, Vistin Pharma ASA stock appears to be undervalued. The current stock price of kr18.50 is trading 21.9% below its estimated GF Value™ of kr23.70. GuruFocus considers Vistin Pharma ASA to be Modestly Undervalued.

Key valuation signals for OSL:VISTN:

  • Receipts from Customers:
  • GF Value™: kr23.70 vs. price of kr18.50 (21.9% below fair value)
  • GF Score™: 78/100 with 2 warning signs

No single metric tells the full story. See the OSL:VISTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vistin Pharma ASA Business Description

Address Ostensjoveien 27, P.O. Box 6735 Etterstad, Oslo, NOR, 0661
Vistin Pharma ASA is a pharmaceutical company engaged in the production and supply of active pharmaceutical ingredients (APIs). The company operates in one business segment, Pharmaceuticals, and is a supplier of Metformin, which is used as a standard treatment for Type 2 diabetes. The company generates revenue across multiple geographic regions, including Africa, Europe, Asia, and North and South America.
78GF Score

Get the complete analysis for OSL:VISTN

Receipts from Customers is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr18.50
Price
kr23.70
GF Value